⌕
Veracyte · VCYT · Nasdaq
Tenet 78 · Strong
Compare
$24.01−1.32%At closeTenet 78 · Strong
$24.01−0.32 (−1.32%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Veracyte (VCYT) Stock

Veracyte (VCYT) closed at $24.01 on Nov 16, 2026; its Tenet Score is 78 of 100 against 313 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

5 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$24.01
Nov 16, 2026
Market cap
$2.0B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
15.9×
price ÷ earnings
52-week range
21.91 – 60.91
low → high · as of close, Nov 13, 2026
Tenet Score
78/100
Strong · 313 Healthcare peers

Industry: Drugs

Veracyte Inc scores 78/100. Strong. Strongest on growth and value, trading at 16× earnings versus 313 Healthcare peers.

Tenet Score · vs sector

n=313
78/ 100
Strong
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
82
Quality
68
Health
76
Growth
86

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueBQualityCHealthBGrowthBMomentumD
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
1.4×
price to book value
P/S
3.4×
price to fiscal 2025 sales
ROE
9%
return on equity
Operating margin
11.2%
fiscal 2025, before interest and tax
Net margin
21.8%
of revenue kept
Current ratio
5.56
current assets to liabilities
Net debt / EBITDA
−3.1×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Veracyte Inc

Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prosta…

Composite computed Nov 13, 2026 · peer basis: Healthcare (n=313) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 141 US ETFs · top wrappers by weightSee all ETFs holding VCYT →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Veracyte in?

Veracyte is in the Healthcare sector and the Drugs industry.

What is Veracyte's Tenet Score?

Veracyte's Tenet Score is 78 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.